APO RESEARCH · REPORT
Amoxicillin
Amoxicillin is an antibiotic often used for the treatment of a number of bacterial infections. It may be used for middle ear infection, strep throat, pneumonia, skin infections, and urinary tract infections among others. It is taken by mouth, or less commonly by injection.
Product & engineering
Understand the product.
Amoxicillin is an antibiotic often used for the treatment of a number of bacterial infections. It may be used for middle ear infection, strep throat, pneumonia, skin infections, and urinary tract infections among others. It is taken by mouth, or less commonly by injection.
Selected research
Industry Research
Amoxicillin Industry Research Report 2026
Market perspective
Amoxicillin is an antibiotic often used for the treatment of a number of bacterial infections. It may be used for middle ear infection, strep throat, pneumonia, skin infections, and urinary tract infections among others. It is taken by mouth, or less commonly by injection.
Global Amoxicillin main players include GSK, Novartis, Centrient Pharma, Teva, Mylan, Cipla, NCPC, United Laboratories, Sun Pharma, CSPC, LKPC, Hikma, Dr. Reddy, HPGC, Aurubindo, Meiji Holdings, etc., totally accounting for about 48%. Europe is the largest market, with a share over 29%. As for the types of products, it can be divided into capsule, tablet and others. The most common product is capsulee, holding a share over 80%. In terms of applications, it is widely used in hospital pharmacy, retail pharmacy and online pharmacy. The most application is retail pharmac, with a share over 62%.
Report Scope
Read the full market overview
This report quantifies the global Amoxicillin market in terms of revenue (US$ million) and, where applicable, sales volume (M Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/M Units) and concentration ratios (CR5/CR10).
The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.
Key Companies & Market Share Insights
This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Amoxicillin Market by Company
GSK
Novartis
Centrient Pharma
Teva
Mylan
Cipla
NCPC
United Laboratories
Sun Pharma
CSPC
LKPC
Hikma
Dr. Reddy
HPGC
Aurubindo
Meiji Holdings
Amoxicillin Segment by Type
Capsule
Tablet
Others
Amoxicillin Segment by Application
Hospital Pharmacy
Retail Pharmacy
Online Pharmacy
Amoxicillin Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Amoxicillin market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Amoxicillin and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Amoxicillin.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of Amoxicillin manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of Amoxicillin by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of Amoxicillin in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Capsule
- Tablet
- Others
Applications
- Hospital Pharmacy
- Retail Pharmacy
- Online Pharmacy
Companies covered
- GSK
- Novartis
- Centrient Pharma
- Teva
- Mylan
- Cipla
- NCPC
- United Laboratories
- Sun Pharma
- CSPC
- LKPC
- Hikma
- Dr. Reddy
- HPGC
- Aurubindo
- Meiji Holdings
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Global Market Growth Prospects
- 2.2.1 Global Amoxicillin Market Size (2021-2032)
- 2.2.2 Global Amoxicillin Sales (2021-2032)
- 2.2.3 Global Amoxicillin Market Average Price (2021-2032)
- 2.3 Amoxicillin by Type
- 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
- 2.3.2 Capsule
- 2.3.3 Tablet
- 2.3.4 Others
- 2.4 Amoxicillin by Application
- 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.4.2 Hospital Pharmacy
- 2.4.3 Retail Pharmacy
- 2.4.4 Online Pharmacy
3 Market Competitive Landscape by Manufacturers
- 3.1 Global Amoxicillin Market Competitive Situation by Manufacturers (2021 Versus 2025)
- 3.2 Global Amoxicillin Sales (M Units) of Manufacturers (2021-2026)
- 3.3 Global Amoxicillin Revenue of Manufacturers (2021-2026)
- 3.4 Global Amoxicillin Average Price by Manufacturers (2021-2026)
- 3.5 Global Amoxicillin Industry Ranking, 2024 VS 2025 VS 2026
- 3.6 Global Manufacturers of Amoxicillin, Manufacturing Sites & Headquarters
- 3.7 Global Manufacturers of Amoxicillin, Product Type & Application
- 3.8 Global Manufacturers of Amoxicillin, Established Date
- 3.9 Global Amoxicillin Market CR5 and HHI
- 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
- 4.1 GSK
- 4.1.1 GSK Company Information
- 4.1.2 GSK Business Overview
- 4.1.3 GSK Amoxicillin Sales, Revenue and Gross Margin (2021-2026)
- 4.1.4 GSK Amoxicillin Product Portfolio
- 4.1.5 GSK Recent Developments
- 4.2 Novartis
- 4.2.1 Novartis Company Information
- 4.2.2 Novartis Business Overview
- 4.2.3 Novartis Amoxicillin Sales, Revenue and Gross Margin (2021-2026)
- 4.2.4 Novartis Amoxicillin Product Portfolio
- 4.2.5 Novartis Recent Developments
- 4.3 Centrient Pharma
- 4.3.1 Centrient Pharma Company Information
- 4.3.2 Centrient Pharma Business Overview
- 4.3.3 Centrient Pharma Amoxicillin Sales, Revenue and Gross Margin (2021-2026)
- 4.3.4 Centrient Pharma Amoxicillin Product Portfolio
- 4.3.5 Centrient Pharma Recent Developments
- 4.4 Teva
- 4.4.1 Teva Company Information
- 4.4.2 Teva Business Overview
- 4.4.3 Teva Amoxicillin Sales, Revenue and Gross Margin (2021-2026)
- 4.4.4 Teva Amoxicillin Product Portfolio
- 4.4.5 Teva Recent Developments
- 4.5 Mylan
- 4.5.1 Mylan Company Information
- 4.5.2 Mylan Business Overview
- 4.5.3 Mylan Amoxicillin Sales, Revenue and Gross Margin (2021-2026)
- 4.5.4 Mylan Amoxicillin Product Portfolio
- 4.5.5 Mylan Recent Developments
- 4.6 Cipla
- 4.6.1 Cipla Company Information
- 4.6.2 Cipla Business Overview
- 4.6.3 Cipla Amoxicillin Sales, Revenue and Gross Margin (2021-2026)
- 4.6.4 Cipla Amoxicillin Product Portfolio
- 4.6.5 Cipla Recent Developments
- 4.7 NCPC
- 4.7.1 NCPC Company Information
- 4.7.2 NCPC Business Overview
- 4.7.3 NCPC Amoxicillin Sales, Revenue and Gross Margin (2021-2026)
- 4.7.4 NCPC Amoxicillin Product Portfolio
- 4.7.5 NCPC Recent Developments
- 4.8 United Laboratories
- 4.8.1 United Laboratories Company Information
- 4.8.2 United Laboratories Business Overview
- 4.8.3 United Laboratories Amoxicillin Sales, Revenue and Gross Margin (2021-2026)
- 4.8.4 United Laboratories Amoxicillin Product Portfolio
- 4.8.5 United Laboratories Recent Developments
- 4.9 Sun Pharma
- 4.9.1 Sun Pharma Company Information
- 4.9.2 Sun Pharma Business Overview
- 4.9.3 Sun Pharma Amoxicillin Sales, Revenue and Gross Margin (2021-2026)
- 4.9.4 Sun Pharma Amoxicillin Product Portfolio
- 4.9.5 Sun Pharma Recent Developments
- 4.10 CSPC
- 4.10.1 CSPC Company Information
- 4.10.2 CSPC Business Overview
- 4.10.3 CSPC Amoxicillin Sales, Revenue and Gross Margin (2021-2026)
- 4.10.4 CSPC Amoxicillin Product Portfolio
- 4.10.5 CSPC Recent Developments
- 4.11 LKPC
- 4.11.1 LKPC Company Information
- 4.11.2 LKPC Business Overview
- 4.11.3 LKPC Amoxicillin Sales, Revenue and Gross Margin (2021-2026)
- 4.11.4 LKPC Amoxicillin Product Portfolio
- 4.11.5 LKPC Recent Developments
- 4.12 Hikma
- 4.12.1 Hikma Company Information
- 4.12.2 Hikma Business Overview
- 4.12.3 Hikma Amoxicillin Sales, Revenue and Gross Margin (2021-2026)
- 4.12.4 Hikma Amoxicillin Product Portfolio
- 4.12.5 Hikma Recent Developments
- 4.13 Dr. Reddy
- 4.13.1 Dr. Reddy Company Information
- 4.13.2 Dr. Reddy Business Overview
- 4.13.3 Dr. Reddy Amoxicillin Sales, Revenue and Gross Margin (2021-2026)
- 4.13.4 Dr. Reddy Amoxicillin Product Portfolio
- 4.13.5 Dr. Reddy Recent Developments
- 4.14 HPGC
- 4.14.1 HPGC Company Information
- 4.14.2 HPGC Business Overview
- 4.14.3 HPGC Amoxicillin Sales, Revenue and Gross Margin (2021-2026)
- 4.14.4 HPGC Amoxicillin Product Portfolio
- 4.14.5 HPGC Recent Developments
- 4.15 Aurubindo
- 4.15.1 Aurubindo Company Information
- 4.15.2 Aurubindo Business Overview
- 4.15.3 Aurubindo Amoxicillin Sales, Revenue and Gross Margin (2021-2026)
- 4.15.4 Aurubindo Amoxicillin Product Portfolio
- 4.15.5 Aurubindo Recent Developments
- 4.16 Meiji Holdings
- 4.16.1 Meiji Holdings Company Information
- 4.16.2 Meiji Holdings Business Overview
- 4.16.3 Meiji Holdings Amoxicillin Sales, Revenue and Gross Margin (2021-2026)
- 4.16.4 Meiji Holdings Amoxicillin Product Portfolio
- 4.16.5 Meiji Holdings Recent Developments
5 Global Amoxicillin Market Scenario by Region
- 5.1 Global Amoxicillin Market Size by Region: 2021 VS 2025 VS 2032
- 5.2 Global Amoxicillin Sales by Region: 2021-2032
- 5.2.1 Global Amoxicillin Sales by Region: 2021-2026
- 5.2.2 Global Amoxicillin Sales by Region: 2027-2032
- 5.3 Global Amoxicillin Revenue by Region: 2021-2032
- 5.3.1 Global Amoxicillin Revenue by Region: 2021-2026
- 5.3.2 Global Amoxicillin Revenue by Region: 2027-2032
- 5.4 North America Amoxicillin Market Facts & Figures by Country
- 5.4.1 North America Amoxicillin Market Size by Country: 2021 VS 2025 VS 2032
- 5.4.2 North America Amoxicillin Sales by Country (2021-2032)
- 5.4.3 North America Amoxicillin Revenue by Country (2021-2032)
- 5.4.4 United States
- 5.4.5 Canada
- 5.4.6 Mexico
- 5.5 Europe Amoxicillin Market Facts & Figures by Country
- 5.5.1 Europe Amoxicillin Market Size by Country: 2021 VS 2025 VS 2032
- 5.5.2 Europe Amoxicillin Sales by Country (2021-2032)
- 5.5.3 Europe Amoxicillin Revenue by Country (2021-2032)
- 5.5.4 Germany
- 5.5.5 France
- 5.5.6 U.K.
- 5.5.7 Italy
- 5.5.8 Russia
- 5.5.9 Spain
- 5.5.10 Netherlands
- 5.5.11 Switzerland
- 5.5.12 Sweden
- 5.5.13 Poland
- 5.6 Asia Pacific Amoxicillin Market Facts & Figures by Country
- 5.6.1 Asia Pacific Amoxicillin Market Size by Country: 2021 VS 2025 VS 2032
- 5.6.2 Asia Pacific Amoxicillin Sales by Country (2021-2032)
- 5.6.3 Asia Pacific Amoxicillin Revenue by Country (2021-2032)
- 5.6.4 China
- 5.6.5 Japan
- 5.6.6 South Korea
- 5.6.7 India
- 5.6.8 Australia
- 5.6.9 Taiwan
- 5.6.10 Southeast Asia
- 5.7 South America Amoxicillin Market Facts & Figures by Country
- 5.7.1 South America Amoxicillin Market Size by Country: 2021 VS 2025 VS 2032
- 5.7.2 South America Amoxicillin Sales by Country (2021-2032)
- 5.7.3 South America Amoxicillin Revenue by Country (2021-2032)
- 5.7.4 Brazil
- 5.7.5 Argentina
- 5.7.6 Chile
- 5.8 Middle East and Africa Amoxicillin Market Facts & Figures by Country
- 5.8.1 Middle East and Africa Amoxicillin Market Size by Country: 2021 VS 2025 VS 2032
- 5.8.2 Middle East and Africa Amoxicillin Sales by Country (2021-2032)
- 5.8.3 Middle East and Africa Amoxicillin Revenue by Country (2021-2032)
- 5.8.4 Egypt
- 5.8.5 South Africa
- 5.8.6 Israel
- 5.8.7 Türkiye
- 5.8.8 GCC Countries
6 Segment by Type
- 6.1 Global Amoxicillin Sales by Type (2021-2032)
- 6.1.1 Global Amoxicillin Sales by Type (2021-2032) & (M Units)
- 6.1.2 Global Amoxicillin Sales Market Share by Type (2021-2032)
- 6.2 Global Amoxicillin Revenue by Type (2021-2032)
- 6.2.1 Global Amoxicillin Sales by Type (2021-2032) & (US$ Million)
- 6.2.2 Global Amoxicillin Revenue Market Share by Type (2021-2032)
- 6.3 Global Amoxicillin Price by Type (2021-2032)
7 Segment by Application
- 7.1 Global Amoxicillin Sales by Application (2021-2032)
- 7.1.1 Global Amoxicillin Sales by Application (2021-2032) & (M Units)
- 7.1.2 Global Amoxicillin Sales Market Share by Application (2021-2032)
- 7.2 Global Amoxicillin Revenue by Application (2021-2032)
- 7.2.1 Global Amoxicillin Sales by Application (2021-2032) & (US$ Million)
- 7.2.2 Global Amoxicillin Revenue Market Share by Application (2021-2032)
- 7.3 Global Amoxicillin Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
- 8.1 Amoxicillin Value Chain Analysis
- 8.1.1 Amoxicillin Key Raw Materials
- 8.1.2 Raw Materials Key Suppliers
- 8.1.3 Amoxicillin Production Mode & Process
- 8.2 Amoxicillin Sales Channels Analysis
- 8.2.1 Direct Comparison with Distribution Share
- 8.2.2 Amoxicillin Distributors
- 8.2.3 Amoxicillin Customers
9 Global Amoxicillin Analyzing Market Dynamics
- 9.1 Amoxicillin Industry Trends
- 9.2 Amoxicillin Industry Drivers
- 9.3 Amoxicillin Industry Opportunities and Challenges
- 9.4 Amoxicillin Industry Restraints
10 Report Conclusion
11 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst